Ibex Investors’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,705	Closed	-$210K	–	214
2018 Q3	$210K	Buy	+1,705	New	+$210K	0.12%	110
2018 Q1	–	Sell	-3,352	Closed	-$263K	–	235
2017 Q4	$263K	Buy	+3,352	New	+$263K	0.15%	96